American Century Companies Inc. raised its holdings in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 1.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 281,537 shares of the software maker’s stock after buying an additional 5,003 shares during the period. American Century Companies Inc. owned approximately 0.16% of Allscripts Healthcare Solutions worth $3,592,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of MDRX. FNY Partners Fund LP boosted its position in Allscripts Healthcare Solutions by 900.0% in the 1st quarter. FNY Partners Fund LP now owns 8,000 shares of the software maker’s stock valued at $101,000 after buying an additional 7,200 shares during the period. Invictus RG purchased a new position in Allscripts Healthcare Solutions in the 1st quarter valued at approximately $105,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Allscripts Healthcare Solutions by 9.5% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,434 shares of the software maker’s stock valued at $120,000 after buying an additional 816 shares during the period. Flinton Capital Management LLC boosted its position in Allscripts Healthcare Solutions by 4.1% in the 1st quarter. Flinton Capital Management LLC now owns 9,940 shares of the software maker’s stock valued at $126,000 after buying an additional 392 shares during the period. Finally, Bank of Montreal Can boosted its position in Allscripts Healthcare Solutions by 60.2% in the 1st quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock valued at $126,000 after buying an additional 3,724 shares during the period.

Several equities analysts have commented on MDRX shares. Bank of America Corporation started coverage on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. They issued a “neutral” rating and a $14.00 price target for the company. Maxim Group reaffirmed a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $13.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, May 15th. BidaskClub raised shares of Allscripts Healthcare Solutions from a “strong sell” rating to a “sell” rating in a research report on Tuesday, June 13th. Finally, Leerink Swann cut shares of Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from $15.00 to $13.00 in a research report on Monday, June 19th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eleven have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $14.81.

TRADEMARK VIOLATION WARNING: This piece was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/12/american-century-companies-inc-acquires-5003-shares-of-allscripts-healthcare-solutions-inc-mdrx.html.

Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ MDRX) opened at 13.50 on Tuesday. The firm’s market capitalization is $2.44 billion. The company’s 50-day moving average is $12.77 and its 200 day moving average is $12.33. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $13.97.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 EPS for the quarter, missing the Zacks’ consensus estimate of $0.15 by $0.04. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The company had revenue of $426.10 million for the quarter, compared to the consensus estimate of $424.94 million. During the same quarter last year, the company earned $0.14 earnings per share. The company’s revenue was up 10.2% compared to the same quarter last year. Analysts anticipate that Allscripts Healthcare Solutions, Inc. will post $0.62 EPS for the current fiscal year.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.